Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1274 studies found for:    GLP-1
Show Display Options
Rank Status Study
1 Recruiting Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting
Conditions: Right Coronary Artery Percutaneous Coronary Intervention;   Right Ventricular Diastolic Dysfunction
Interventions: Procedure: Right Coronary Artery Percutaneous Coronary Intervention;   Other: saline placebo infusion;   Other: GLP-1 Infusion
2 Completed Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
Conditions: Diabetes Mellitus Type 2;   Hyperglycemia
Interventions: Drug: GLP-1;   Drug: Human regular insulin intravenously
3 Terminated GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage (ICH)
Intervention: Drug: GLP-1 CellBeads
4 Recruiting Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Condition: GLP-1;Metformin;Telomere-telomerase System;Par-4
Interventions: Drug: Liraglutide;   Drug: Metformin
5 Completed Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
Condition: Healthy
Intervention: Drug: native glp-1 (7-36)
6 Completed GLP-1 Infusion and Long-Time Fasting
Condition: Type 2 Diabetes
Interventions: Drug: Glucagon-like-peptide-1 (7-36) amide;   Drug: Placebo
7 Recruiting GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
Condition: Functional Gastrointestinal Disorders
Interventions: Biological: GLP-1;   Biological: Intravenous saline
8 Recruiting GLP-1 Loading During Elective Percutaneous Coronary Intervention
Conditions: Angina Pectoris;   Myocardial Infarction;   Reperfusion Injury;   Coronary Heart Disease
Interventions: Drug: GLP-1;   Drug: placebo
9 Unknown  GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Condition: Healthy
Interventions: Other: 1,5 nmol/kg,GLP-1 sc injection;   Other: 1,5 nmol/kg GLP-1 9-36amide, sc injection;   Other: Exendin-4 ;10 ug,sc injection;   Other: saline
10 Completed
Has Results
GLP1R Polymorphisms and Response to GLP1
Condition: Diabetes
Intervention: Drug: GLP-1
11 Unknown  Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery
Condition: CABG
Interventions: Drug: Placebo;   Drug: GLP-1 (7-36) amide
12 Completed Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans
Condition: Hyperglycemia
Interventions: Drug: GLP-1 control;   Drug: GLP-1 and Exendin(9-39) 300;   Drug: saline control;   Drug: GLP-1 and Exendin(9-39) 600;   Drug: GLP-1 and Exendin(9-39) 900;   Drug: GLP-1 and Exendin(9-39) 1200
13 Completed The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers
Condition: Prediabetes
Intervention: Other: Oral glucose tolerance
14 Completed Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
Condition: Metabolic Syndrome
Intervention: Drug: GLP-1 infusion
15 Completed Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)
Conditions: Hyperglycemia;   Hyperglucagonemia;   Glucose Intolerance
Intervention: Other: GLP-1 infusion
16 Terminated Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
Condition: Obesity
Interventions: Drug: GLP-1 (Liraglutide);   Drug: Placebo
17 Completed Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
Conditions: Coronary Artery Disease;   Diabetes Mellitus Type 2
Intervention: Drug: Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere
18 Recruiting Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
Condition: Post-bariatric Surgery
Interventions: Drug: exendin-(9-39);   Drug: exendin -(9-39)
19 Unknown  Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: High Calorie Breakfast (BTdiet);   Other: High Caloric Dinner (DTdiet)
20 Completed Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
Condition: Glucose Homeostasis
Interventions: Drug: Oral GLP-1;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.